Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences Team, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology
Brings Total Series B Funds Raised to Nearly $100 Million Proceeds to Support Broadening Scope of Ongoing Clinical Trial of…
